nivolumab
bms
['nadim ii', 'nadim', 'nsclc', 'nivo', 'sclc']
#asco22 nivo+chemo versus chemo as neoadj try for resect stiiia nsclc: phase ii nadim ii by sx 93% vs 69%, p=0.0071 pcr= 36.8% vs 6.9%, p=0.0068 mpr=52.6% vs 14% orr=75.4% vs 48.2%
solid data for chemoio as soc in stiiia 
#MedicalOncologist MSc Transl Res Univ Paris Sud   #LungCancer biology, immunotherapy, clinical trials #LCSM @myESMO faculty #OncoAlert   live to give